Maccura Biotechnology Co Ltd (300463) — Cash Flow-to-Debt Ratio
Maccura Biotechnology Co Ltd (300463) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥148.82 Million could theoretically repay 0% of its total liabilities (CN¥1.61 Billion) in one year. Explore Maccura Biotechnology Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Maccura Biotechnology Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Maccura Biotechnology Co Ltd across 15 annual periods. Also explore 300463 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Maccura Biotechnology Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Maccura Biotechnology Co Ltd. For market capitalisation and broader financial context, see 300463 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | CN¥602.33 Million | CN¥1.69 Billion | ▼ -12.6% |
| 2024 | 0.41x | CN¥633.80 Million | CN¥1.55 Billion | ▼ -32.5% |
| 2023 | 0.60x | CN¥912.09 Million | CN¥1.51 Billion | ▲ +17.1% |
| 2022 | 0.52x | CN¥843.22 Million | CN¥1.63 Billion | ▼ -35.3% |
| 2021 | 0.80x | CN¥1.62 Billion | CN¥2.03 Billion | ▲ +72.2% |
| 2020 | 0.46x | CN¥1.09 Billion | CN¥2.36 Billion | ▲ +118.9% |
| 2019 | 0.21x | CN¥459.52 Million | CN¥2.17 Billion | ▲ +84.8% |
| 2018 | 0.11x | CN¥193.91 Million | CN¥1.69 Billion | ▲ +40.7% |
| 2017 | 0.08x | CN¥79.03 Million | CN¥970.12 Million | ▼ -31.4% |
| 2016 | 0.12x | CN¥49.32 Million | CN¥415.01 Million | ▲ +33.1% |
| 2015 | 0.09x | CN¥33.18 Million | CN¥371.71 Million | ▼ -67.1% |
| 2014 | 0.27x | CN¥115.09 Million | CN¥424.27 Million | ▼ -35.9% |
| 2013 | 0.42x | CN¥98.39 Million | CN¥232.53 Million | ▼ -28.9% |
| 2012 | 0.59x | CN¥110.96 Million | CN¥186.54 Million | ▲ +34.5% |
| 2011 | 0.44x | CN¥85.55 Million | CN¥193.39 Million | — |